These effects, along with a preceding report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 support the principle of targeting ACKR3 as a novel way to modulate the opioid procedure, which could open new therapeutic avenues for opioid-linked Diseases. These effects advise that conolidine is https://stratfordy950mbb7.national-wiki.com/user